Title : MEVITEM-a phase I/II trial of vismodegib + temozolomide vs temozolomide in patients with recurrent/refractory medulloblastoma with Sonic Hedgehog pathway activation.

Pub. Date : 2021 Nov 2

PMID : 33825892






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We report results of a Phase I/II evaluating vismodegib + temozolomide in immunohistochemically defined SHH recurrent/refractory adult medulloblastoma. Temozolomide sonic hedgehog signaling molecule Homo sapiens